Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
about
Interleukin-32 promotes osteoclast differentiation but not osteoclast activationEmerging Functions of RANKL in Lymphoid TissuesTumor metastasis to boneBiology of RANK, RANKL, and osteoprotegerinBiology of recently discovered cytokines: interleukin-17--a unique inflammatory cytokine with roles in bone biology and arthritisEffect of magnolol on the function of osteoblastic MC3T3-E1 cellsGenomic amplification of a decoy receptor for Fas ligand in lung and colon cancerDenosumab for the treatment and prevention of postmenopausal osteoporosisA novel ubiquitin-binding protein ZNF216 functioning in muscle atrophyRole of the A20-TRAF6 axis in lipopolysaccharide-mediated osteoclastogenesisLIGHT, a member of the tumor necrosis factor ligand superfamily, prevents tumor necrosis factor-alpha-mediated human primary hepatocyte apoptosis, but not Fas-mediated apoptosisReceptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesisRANK is essential for osteoclast and lymph node developmentA comprehensive manually curated reaction map of RANKL/RANK-signaling pathwayOsteoclast differentiation factor RANKL controls development of progestin-driven mammary cancerControl of RANKL gene expressionActivated human T cells express alternative mRNA transcripts encoding a secreted form of RANKLTumor necrosis factor receptor-associated factor 6 is an intranuclear transcriptional coactivator in osteoclastsTumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligandOsteoimmunology: interactions of the bone and immune systemIdentification of LRRc17 as a negative regulator of receptor activator of NF-kappaB ligand (RANKL)-induced osteoclast differentiationEffect of denosumab on Japanese patients with rheumatoid arthritis: a dose-response study of AMG 162 (Denosumab) in patients with RheumatoId arthritis on methotrexateJun dimerization protein 2 (JDP2), a member of the AP-1 family of transcription factor, mediates osteoclast differentiation induced by RANKLA novel member of the leukocyte receptor complex regulates osteoclast differentiationGene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formationOsteoclasts: what do they do and how do they do it?Exposure to receptor-activator of NFkappaB ligand renders pre-osteoclasts resistant to IFN-gamma by inducing terminal differentiationThe role of osteoprotegerin in arthritisSerum cathepsin K levels of patients with longstanding rheumatoid arthritis: correlation with radiological destruction.Differentiation of monocytes into multinucleated giant bone-resorbing cells: two-step differentiation induced by nurse-like cells and cytokinesEnhanced osteoclast development in collagen-induced arthritis in interferon-gamma receptor knock-out mice as related to increased splenic CD11b+ myelopoiesisBone loss. Factors that regulate osteoclast differentiation: an update.The role of TNF-receptor family members and other TRAF-dependent receptors in bone resorption.Bone loss. Therapeutic approaches for preventing bone loss in inflammatory arthritisHuman primary osteoclasts: in vitro generation and applications as pharmacological and clinical assayUnsatisfactory gene transfer into bone-resorbing osteoclasts with liposomal transfection systemsThe Roles of Acidosis in Osteoclast BiologyRANK-RANKL signalling in cancerThe biological function of type I receptors of bone morphogenetic protein in bone
P2860
Q21092154-1D3F9509-7D64-4768-854D-C9424D9464FFQ21131222-C74A2939-57B4-4E19-8ECC-41F3D2ACE931Q21195416-65BE4AC4-276C-48EA-8140-D20EDEC104D9Q21195419-3859BA73-E05A-4C3E-B043-A705FA37C98AQ21195672-9097B285-631C-4092-B2B0-314E082DD373Q21284960-A696241E-681B-4551-9EF4-BA5E4A4DEC11Q22008593-1DC466A4-4A0E-4B1B-90F7-FBF1578DCC46Q24201859-F9228230-7747-4205-97CA-E693D3EDFD08Q24301547-F89FDB1C-D846-4199-94FA-BCCC8C010C89Q24311417-7CAF99D4-592B-411D-88DF-87AFCE502420Q24312907-D3F5471F-710A-4507-AD3A-4CAA03325846Q24537518-1543998C-AFC5-4E13-97AB-C7309AF75975Q24563235-7616580F-8A4B-4563-B070-2FEC9D562F50Q24598872-B235469F-DDD8-4568-B40D-6EE17C5A64C5Q24599024-A818723D-FDFC-4D44-9F5D-069D9F99DE81Q24605866-D8D72F6F-5D34-47DB-B17B-152852F8D81CQ24619669-947CEF6F-B7BF-4DBA-B6BA-FF1DA82E34D9Q24632345-2D10328C-6045-448C-92BD-5662B4123834Q24651323-BAE3187E-75B6-40B8-816D-CD675B7E710BQ24653311-048625F2-C963-415E-86CD-1BA2E2A95C83Q24655113-DA3D0B03-007C-4DA9-8C01-A5D5D89D5A3DQ24657159-6736248C-BC3F-45E8-9904-E6A8A5641856Q24658507-7BF18D29-235D-4860-A47D-2B5CFC04001CQ24673624-65D8109D-F0C2-4BA5-AF1B-E9685922EC73Q24675157-7ACF5136-264D-488B-A9D4-CF7316290AC6Q24681552-0524EAF4-851D-4A1D-A350-773BC02E088AQ24683898-7D6E07DE-4867-4917-9523-751E6D203496Q24796088-C3004743-23E9-4692-9F5D-A4D19523B0D7Q24797889-921AEA73-5E76-4FEC-87C2-7BAA79E324E8Q24799065-0067725F-20D8-4585-84B1-21BDC2A73DCFQ24799753-83B43859-BDD9-48C7-A328-B96068995CB7Q24800726-2605884C-8B16-44A9-AE98-B71C0A6EFBC8Q24805142-3FA1E2E3-ACC0-4149-9754-AFB49C13B032Q24805207-006D40BC-9423-4D7C-9B45-963B04A21685Q24805600-515E18DB-1F13-457D-A593-BBF928782208Q24806517-8732004C-F51D-445B-9879-719D3CD96043Q24814004-A117CE2B-67CF-4C0F-A193-02594F9F2CA3Q26738322-04FF45EE-6DED-442E-B49D-7F92E26009A5Q26747442-0CC3808D-5F06-4414-BFB8-CE9170333264Q26752839-1679F099-5C43-4A18-B76C-CA4C25594801
P2860
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
description
1998 nî lūn-bûn
@nan
1998 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Osteoprotegerin ligand is a cy ...... differentiation and activation
@ast
Osteoprotegerin ligand is a cy ...... differentiation and activation
@en
Osteoprotegerin ligand is a cy ...... differentiation and activation
@en-gb
Osteoprotegerin ligand is a cy ...... differentiation and activation
@nl
type
label
Osteoprotegerin ligand is a cy ...... differentiation and activation
@ast
Osteoprotegerin ligand is a cy ...... differentiation and activation
@en
Osteoprotegerin ligand is a cy ...... differentiation and activation
@en-gb
Osteoprotegerin ligand is a cy ...... differentiation and activation
@nl
prefLabel
Osteoprotegerin ligand is a cy ...... differentiation and activation
@ast
Osteoprotegerin ligand is a cy ...... differentiation and activation
@en
Osteoprotegerin ligand is a cy ...... differentiation and activation
@en-gb
Osteoprotegerin ligand is a cy ...... differentiation and activation
@nl
P2093
P3181
P1433
P1476
Osteoprotegerin ligand is a cy ...... differentiation and activation
@en
P2093
A Colombero
C Capparelli
P304
P3181
P356
10.1016/S0092-8674(00)81569-X
P407
P577
1998-04-17T00:00:00Z